Topic: Novartis AG
Novartis seals Alcon takeover after cash deal with eye care company's minority shareholdersSwiss pharmaceutical company Novartis AG said Wednesday it has reached a deal with minority shareholders of Alcon Inc. to complete its $51 billion takeover of the eye care company, the ...
Zaditor (ketotifen fumarate) Antihistamine Eye Drops, registered by Novartis, were prescription only until recently released to be sold over the counter. Zaditor is the brand name of the ketotifen fumarate ophthalmic solution manufactured and distributed by Novartis Pharmaceuticals. The generic brands are ...
QLT Inc. (QLTI) Q1 2010 Earnings Call May 06, 2010 8:30 am ET. Turning briefly to our commercial efforts for Visudyne in the U.S., we've had our sales team in place since January and the team completed their first round of calls ...
Novartis (NVS) is pursuing plans to acquire the eye-care business Alcon (ACL) from Nestle (NSRGY. But Alcon's minority shareholders are angry because Novartis is offering them just $153 per share while paying Nestle $180 per share for its 52 percent stake. The ...
Swiss pharmaceuticals giant Novartis on Monday made a 40-billion-dollar play for the fast growing eye-care market, aiming to take over Alcon, the world's biggest company in a sector driven by an ageing population.Combined, Alcon and Novartis would have about 70 percent of ...
ACL) reported global sales of $1,735.2 million for the second quarter of 2008, an increase of 17.9 percent compared to the second quarter of 2007, or 11.2 percent excluding the impact of foreign exchange fluctuations. "The results for the second quarter demonstrate ...